Literature DB >> 23912667

Evaluation of central corneal and central retinal thicknesses and intraocular pressure in acromegaly patients.

Sefika Burcak Polat1, Nagihan Ugurlu, Reyhan Ersoy, Oguzhan Oguz, Necati Duru, Bekir Cakir.   

Abstract

INTRODUCTION: Acromegaly is a disorder with increased morbidity which can involve many organs and the eye can be one of them which was investigated in few reports. Herein, we aimed to evaluate CCT, IOP and retinal thickness (RT), and their relationships with serum GH and IGF-1 levels and disease duration, in acromegaly patients. We compared the ocular parameters with those of a control group. This study included the largest number of patients of any comparable investigation to date. MATERIAL AND
METHOD: We enrolled 30 acromegaly patients (15 male, 15 female and age: 48.4 ± 12.8 years) and 21 age and gender matched controls. All participants underwent complete hormonal and ophtalmological evaluation including central corneal thickness (CCT), retinal thickness (RT) and intraocular pressure (IOP) values.
RESULTS: There were no significant differences in median right and left CCTs and mean CCT (p = 0.646, p = 0.667 and p = 0.384, respectively). Nor were there statistically significant differences in median right and left RT, or mean central RT, between the acromegaly and control groups (p = 0.977, p = 0.738 and p = 0.811, respectively). However median right, left and mean IOPs were found to be significantly higher in the acromegaly group, despite there being no difference in the CCT values (p = 0.011, p = 0.028 and p = 0.047, respectively). When we analyzed two subgroups of acromegaly patients (active/inactive), we found that the median right, left and mean CCTs and RTs, were not significantly different between the groups. Although there was a significant difference in IOP between the acromegaly and control groups, the two subgroups of acromegaly patients had similar IOPs (p = 0.400, p = 0.621 and p = 0.451 for right, left and mean IOPs, respectively). IOP was not found to be correlated with serum IGF-I, GH or disease duration in acromegaly patients.
CONCLUSION: Our study results suggest that acromegaly is associated with increased ocular pressures irrespective of disease activity. Therefore detailed ocular evaluation should be a routine component of the follow up visits of acromegaly patients.

Entities:  

Mesh:

Year:  2014        PMID: 23912667     DOI: 10.1007/s11102-013-0505-1

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  22 in total

1.  Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women.

Authors:  Louis R Pasquale; Jae Hee Kang; JoAnn E Manson; Walter C Willett; Bernard A Rosner; Susan E Hankinson
Journal:  Ophthalmology       Date:  2006-06-06       Impact factor: 12.079

2.  Intraocular pressure correlated with arterial blood pressure: the beijing eye study.

Authors:  Liang Xu; Han Wang; Yaxing Wang; Jost B Jonas
Journal:  Am J Ophthalmol       Date:  2007-09       Impact factor: 5.258

3.  Vitrectomy after intracapsular cataract extraction in diabetic sequelae.

Authors:  P Algvere
Journal:  Acta Ophthalmol (Copenh)       Date:  1979-08

Review 4.  Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach.

Authors:  M J Doughty; M L Zaman
Journal:  Surv Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 6.048

5.  Central corneal thickness in low-tension glaucoma.

Authors:  N Ehlers; F K Hansen
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

6.  GH secretion in open-angle glaucoma.

Authors:  A V Greco; B Ricci; L Altomonte; A G Rebuzzi; R Manna; G Ghirlanda
Journal:  Ophthalmologica       Date:  1979       Impact factor: 3.250

7.  Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells.

Authors:  D M Martin; D Yee; E L Feldman
Journal:  Brain Res Mol Brain Res       Date:  1992-01

Review 8.  Growth hormone in the nervous system: autocrine or paracrine roles in retinal function?

Authors:  S Harvey; M Kakebeeke; A E Murphy; E J Sanders
Journal:  Can J Physiol Pharmacol       Date:  2003-04       Impact factor: 2.273

9.  Pseudopapilledema and congenital disc anomalies in growth hormone deficiency.

Authors:  P F Collett-Solberg; G T Liu; M Satin-Smith; L L Katz; T Moshang
Journal:  J Pediatr Endocrinol Metab       Date:  1998 Mar-Apr       Impact factor: 1.634

10.  Central corneal thickness and intraocular tension in patients with acromegaly.

Authors:  T Bramsen; A Klauber; P Bjerre
Journal:  Acta Ophthalmol (Copenh)       Date:  1980-12
View more
  9 in total

1.  Evaluation of macular and peripapillary choroidal thickness, macular volume and retinal nerve fiber layer in acromegaly patients.

Authors:  Serpil Yazgan; Dilek Arpaci; Haci Ugur Celik; Irem Isik
Journal:  Int Ophthalmol       Date:  2017-05-15       Impact factor: 2.031

2.  Retina ganglion cell/inner plexiform layer and peripapillary nerve fiber layer thickness in patients with acromegaly.

Authors:  Muhammed Şahin; Alparslan Şahin; Faruk Kılınç; Harun Yüksel; Zeynep Gürsel Özkurt; Fatih Mehmet Türkcü; Zafer Pekkolay; Hikmet Soylu; İhsan Çaça
Journal:  Int Ophthalmol       Date:  2016-08-04       Impact factor: 2.031

3.  Chorio-retinal thickness measurements in patients with acromegaly.

Authors:  G Pekel; F Akin; M S Ertürk; S Acer; R Yagci; M C Hıraali; E N Cetin
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

4.  Ocular findings in Sheehan's syndrome.

Authors:  Murat Atmaca; Esra Kızıldağ; Zehra Candan; Mehmet Fatih Özbay; İsmet Seven
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-10       Impact factor: 3.117

5.  Corneal biomechanical properties measured by the ocular response analyzer in acromegalic patients.

Authors:  Emine Sen; Yasemin Tutuncu; Melike Balikoglu-Yilmaz; Ufuk Elgin; Dilek Berker; Faruk Ozturk; Serdar Guler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-13       Impact factor: 3.117

6.  Elevated intraocular pressure in patients with acromegaly.

Authors:  Luciano Quaranta; Ivano Riva; Gherardo Mazziotti; Teresa Porcelli; Irene Floriani; Andreas Katsanos; Andrea Giustina; Anastasios G P Konstas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-10       Impact factor: 3.117

7.  Comparing acromegalic patients to healthy controls with respect to intraocular pressure, central corneal thickness, and optic disc topography findings.

Authors:  Emine Sen; Yasemin Tutuncu; Ufuk Elgin; Melike Balikoglu-Yilmaz; Dilek Berker; F Nur Aksakal; Faruk Ozturk; Serdar Guler
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

8.  Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections.

Authors:  Barbara Strzalka-Mrozik; Malgorzata Kimsa-Furdzik; Adam Kabiesz; Katarzyna Michalska-Malecka; Malgorzata Nita; Urszula Mazurek
Journal:  Clin Interv Aging       Date:  2017-09-05       Impact factor: 4.458

9.  Comparing two acromegalic patients with respect to central corneal thickness, intraocular pressure, and tear insulin-like growth factor levels before and after treatment.

Authors:  Kan Emrah; Kilic Kan Elif; Okuyucu Ali
Journal:  Indian J Ophthalmol       Date:  2015-09       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.